HORIBA, Ltd. Financial Highlights for the Year Ended December 31, 2022
(From January 1, 2022 to December 31, 2022)
1. Consolidated Financial Results | Amount : Millions of yen | |||||||
12/2021 | 12/2022 | Changes | 12/2023 | Changes | 12/2023 | Changes | ||
Results | Results | Forecasts | Forecasts | |||||
Full Year | Full Year | Amount | Ratio | Full Year | Amount | 1st Half | Amount | |
Net Sales | 224,314 | 270,133 | +45,819 | +20.4% | 290,000 | +19,866 | 128,000 | +13,034 |
Operating Income | 32,046 | 45,843 | +13,796 | +43.1% | 46,000 | +156 | 19,000 | +2,739 |
Operating Income Ratio | 14.3% | 17.0% | +2.7P | 15.9% | -1.1P | 14.8% | +0.7P | |
Ordinary Income | 32,038 | 46,860 | +14,822 | +46.3% | 45,500 | -1,360 | 18,800 | +2,015 |
Ordinary Income Ratio | 14.3% | 17.3% | +3.0P | 15.7% | -1.6P | 14.7% | +0.1P | |
Net Income Attributable | 21,311 | 34,072 | +12,760 | +59.9% | 35,500 | +1,427 | 17,000 | +5,759 |
to Owners of Parent | ||||||||
Net Income Ratio | 9.5% | 12.6% | +3.1P | 12.2% | -0.4P | 13.3% | +3.5P | |
US$ | 109.90 | 131.62 | +21.72 | 130.00 | -1.62 | 130.00 | +6.86 | |
Euro | 129.91 | 138.14 | +8.23 | 140.00 | +1.86 | 140.00 | +5.61 | |
2. Consolidated Segment Results | Amount : Millions of yen | |||||||
12/2021 | 12/2022 | Changes | 12/2023 | Changes | 12/2023 | Changes | ||
Net Sales | Results | Results | Forecasts | Forecasts | ||||
Full Year | Full Year | Amount | Ratio | Full Year | Amount | 1st Half | Amount | |
Automotive | 61,249 | 67,524 | +6,274 | +10.2% | 79,000 | +11,475 | 30,000 | +4,311 |
Process&Environmental | 20,217 | 22,541 | +2,324 | +11.5% | 25,000 | +2,458 | 11,000 | +808 |
Medical-Diagnostics | 25,882 | 29,753 | +3,870 | +15.0% | 31,000 | +1,246 | 15,000 | +1,326 |
Semiconductor | 87,004 | 114,075 | +27,070 | +31.1% | 115,000 | +924 | 54,000 | +4,578 |
Scientific | 29,958 | 36,239 | +6,280 | +21.0% | 40,000 | +3,760 | 18,000 | +2,010 |
Total | 224,314 | 270,133 | +45,819 | +20.4% | 290,000 | +19,866 | 128,000 | +13,034 |
12/2021 | 12/2022 | Changes | 12/2023 | Changes | 12/2023 | Changes | ||
Operating Income | Results | Results | Forecasts | Forecasts | ||||
Full Year | Full Year | Amount | Ratio | Full Year | Amount | 1st Half | Amount | |
Automotive | (13) | (667) | -654 | - | 500 | +1,167 | (1,500) | +262 |
Process&Environmental | 1,947 | 2,101 | +153 | +7.9% | 2,500 | +398 | 1,000 | +361 |
Medical-Diagnostics | 148 | (99) | -248 | - | 500 | +599 | - | +162 |
Semiconductor | 28,006 | 42,005 | +13,999 | +50.0% | 38,500 | -3,505 | 18,000 | +1,219 |
Scientific | 1,957 | 2,503 | +546 | +27.9% | 4,000 | +1,496 | 1,500 | +734 |
Total | 32,046 | 45,843 | +13,796 | +43.1% | 46,000 | +156 | 19,000 | +2,739 |
3. Consolidated Segment Sales by Destination | Amount : Millions of yen | |||||
12/2021 | 12/2022 | Changes | 12/2023 | Changes | ||
Results | Results | Forecasts | ||||
Full Year | Full Year | Amount | Ratio | Full Year | Amount | |
Automotive | 61,249 | 67,524 | +6,274 | +10.2% | 79,000 | +11,475 |
Japan | 17,365 | 16,555 | -809 | -4.7% | 16,500 | -55 |
Asia | 15,842 | 14,339 | -1,502 | -9.5% | 20,700 | +6,360 |
Americas | 6,475 | 8,110 | +1,634 | +25.2% | 10,400 | +2,289 |
Europe | 21,566 | 28,518 | +6,951 | +32.2% | 31,400 | +2,881 |
Process&Environmental | 20,217 | 22,541 | +2,324 | +11.5% | 25,000 | +2,458 |
Japan | 10,286 | 10,861 | +574 | +5.6% | 11,800 | +938 |
Asia | 5,046 | 5,585 | +538 | +10.7% | 6,300 | +714 |
Americas | 2,281 | 3,002 | +721 | +31.6% | 3,000 | -2 |
Europe | 2,603 | 3,092 | +489 | +18.8% | 3,900 | +807 |
Medical-Diagnostics | 25,882 | 29,753 | +3,870 | +15.0% | 31,000 | +1,246 |
Japan | 5,243 | 6,363 | +1,120 | +21.4% | 6,700 | +336 |
Asia | 5,714 | 7,102 | +1,388 | +24.3% | 7,500 | +397 |
Americas | 5,816 | 6,517 | +701 | +12.1% | 8,100 | +1,582 |
Europe | 9,108 | 9,769 | +660 | +7.3% | 8,700 | -1,069 |
Semiconductor | 87,004 | 114,075 | +27,070 | +31.1% | 115,000 | +924 |
Japan | 26,833 | 32,469 | +5,635 | +21.0% | 35,000 | +2,530 |
Asia | 44,857 | 59,509 | +14,651 | +32.7% | 61,000 | +1,490 |
Americas | 9,813 | 15,269 | +5,456 | +55.6% | 13,000 | -2,269 |
Europe | 5,500 | 6,827 | +1,327 | +24.1% | 6,000 | -827 |
Scientific | 29,958 | 36,239 | +6,280 | +21.0% | 40,000 | +3,760 |
Japan | 6,686 | 7,117 | +431 | +6.5% | 9,000 | +1,882 |
Asia | 8,057 | 11,935 | +3,878 | +48.1% | 13,900 | +1,964 |
Americas | 8,992 | 10,460 | +1,468 | +16.3% | 9,700 | -760 |
Europe | 6,223 | 6,725 | +501 | +8.1% | 7,400 | +674 |
Total | 224,314 | 270,133 | +45,819 | +20.4% | 290,000 | +19,866 |
Japan | 66,414 | 73,367 | +6,953 | +10.5% | 79,000 | +5,632 |
Asia | 79,517 | 98,472 | +18,954 | +23.8% | 109,400 | +10,927 |
Americas | 33,379 | 43,360 | +9,981 | +29.9% | 44,200 | +839 |
Europe | 45,002 | 54,933 | +9,930 | +22.1% | 57,400 | +2,466 |
5. Consolidated Financial Results (Quarterly Comparison) | Amount : Millions of yen | |||||||
12/2021 Results | 12/2022 Results | |||||||
1Q | 2Q | 3Q | 4Q | 1Q | 2Q | 3Q | 4Q | |
Net Sales | 48,582 | 52,734 | 52,639 | 70,356 | 55,510 | 59,454 | 70,156 | 85,012 |
Operating Income | 5,936 | 7,133 | 6,789 | 12,187 | 8,605 | 7,654 | 12,311 | 17,271 |
Operating Income Ratio | 12.2% | 13.5% | 12.9% | 17.3% | 15.5% | 12.9% | 17.5% | 20.3% |
Ordinary Income | 5,885 | 7,161 | 6,820 | 12,169 | 8,743 | 8,041 | 12,723 | 17,351 |
Ordinary Income Ratio | 12.1% | 13.6% | 13.0% | 17.3% | 15.8% | 13.5% | 18.1% | 20.4% |
Net Income Attributable | 3,900 | 4,844 | 4,976 | 7,590 | 5,721 | 5,518 | 9,461 | 13,370 |
to Owners of Parent | ||||||||
Net Income Ratio | 8.0% | 9.2% | 9.5% | 10.8% | 10.3% | 9.3% | 13.5% | 15.7% |
6. Consolidated Segment Results (Quarterly Comparison) | Amount : Millions of yen | |||||||
Net Sales | 12/2021 Results | 12/2022 Results | ||||||
1Q | 2Q | 3Q | 4Q | 1Q | 2Q | 3Q | 4Q | |
Automotive | 12,153 | 12,770 | 12,388 | 23,937 | 13,675 | 12,013 | 15,632 | 26,203 |
Process&Environmental | 5,224 | 4,816 | 4,527 | 5,649 | 4,788 | 5,403 | 5,233 | 7,116 |
Medical-Diagnostics | 6,302 | 6,593 | 6,226 | 6,759 | 6,650 | 7,022 | 7,914 | 8,165 |
Semiconductor | 18,441 | 21,602 | 22,640 | 24,321 | 22,225 | 27,195 | 31,994 | 32,659 |
Scientific | 6,461 | 6,951 | 6,857 | 9,688 | 8,169 | 7,819 | 9,380 | 10,868 |
Total | 48,582 | 52,734 | 52,639 | 70,356 | 55,510 | 59,454 | 70,156 | 85,012 |
Operating Income | 12/2021 Results | 12/2022 Results | ||||||
1Q | 2Q | 3Q | 4Q | 1Q | 2Q | 3Q | 4Q | |
Automotive | (424) | (763) | (747) | 1,921 | 133 | (1,895) | (1,530) | 2,624 |
Process&Environmental | 699 | 414 | 180 | 652 | 453 | 184 | 343 | 1,119 |
Medical-Diagnostics | 164 | 162 | (242) | 63 | 154 | (316) | 140 | (77) |
Semiconductor | 5,257 | 7,093 | 7,370 | 8,284 | 7,180 | 9,600 | 12,468 | 12,757 |
Scientific | 239 | 224 | 228 | 1,265 | 683 | 82 | 890 | 848 |
Total | 5,936 | 7,133 | 6,789 | 12,187 | 8,605 | 7,654 | 12,311 | 17,271 |
Contact
IR・ESG, Corporate Planning Office, Finance and Legal Division, HORIBA, Ltd. 2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto 601-8510, Japan
E-mail:ir-info@horiba.com
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Horiba Ltd. published this content on 14 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 February 2023 06:17:03 UTC.